Phase II Clinical Trial of OCH-NCNP1

Clinical trial NCT04211740 · COMPLETED

Trial details

NCT number: NCT04211740
Sponsor: National Center of Neurology and Psychiatry, Japan
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis, Secondary Progressive

Start date: 2019-12-06
Primary completion: 2023-05-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.